Introduction: On-label and off-label drug use in reproductive medicine

Research output: Contribution to journalArticlepeer-review

5 Scopus citations


This Views and Reviews article examines FDA-approved uses of prescription drugs, as well as common off-label uses of drugs for several disorders that are frequently seen in reproductive medicine. Off-label drug use is ubiquitous in reproductive medicine, a fact that may be related to the disincentives to formally study these drugs in a potentially vulnerable population (i.e., pregnant women). It behooves clinicians to discuss with patients the risk-benefit ratio of treatment, and whether a treatment is FDA-approved for that condition. Researchers, seeking better data on effects of these drugs, may find fodder for future clinical studies in these articles.

Original languageEnglish (US)
Pages (from-to)581-582
Number of pages2
JournalFertility and sterility
Issue number3
StatePublished - Mar 1 2015

All Science Journal Classification (ASJC) codes

  • Reproductive Medicine
  • Obstetrics and Gynecology


Dive into the research topics of 'Introduction: On-label and off-label drug use in reproductive medicine'. Together they form a unique fingerprint.

Cite this